OpGen jumps after private investor to take over as CEO
25/03/2024 22:23
** Shares of diagnostic firm OpGen OPGN.O rise 61% to 76
cents in extended trading
** Co says private investor David Lazar will replace Oliver
Schacht as CEO
** Adds Lazar invests $3 mln in OpGen's preferred stock
** Proceeds of the transaction will be used to repay debt
and for other general corporate and operating purposes -OPGN
** Up to last close, stock up 13% YTD
(Reporting by Mariam Sunny in Bengaluru)
((Mariam.ESunny@thomsonreuters.com;))
Recent news on CapForce
See all newsBrief: Opgen Says Financial Statements Contained Within Quarterly Report On Form 10-Q For Q1 2024 Should No Longer Be Relied Upon
Brief: Opgen Inc - Received Nasdaq Notice That Co Is Not In Compliance With Minimum Stockholders' Equity Requirement For Continued Listing
Brief: OpGen Receives Expected Nasdaq Notice Regarding Delayed Form 10-Q
Brief: OpGen Announces 1-For-10 Reverse Stock Split
Brief: David E. Lazar Reports 19.9% Stake In Opgen Inc As Of March 25- SEC Filing